FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Collections Drugs and Devices, 1940-1963 ✖Remove constraint Collections: Drugs and Devices, 1940-1963 Titles 2526. Adulteration and misbranding of phenobarbital sodium tablets and misbranding of atropine sulfate tablets. U. S. v. 95 Bottles, etc. ✖Remove constraint Titles: 2526. Adulteration and misbranding of phenobarbital sodium tablets and misbranding of atropine sulfate tablets. U. S. v. 95 Bottles, etc. Defendants Retort Pharmaceutical Co., Inc., a wholly owned subsidiary of Cole Laboratories, Inc.; Long Island City, N. Y. The phenobarbital sodium tablets ✖Remove constraint Defendants: Retort Pharmaceutical Co., Inc., a wholly owned subsidiary of Cole Laboratories, Inc.; Long Island City, N. Y. The phenobarbital sodium tablets Issue Dates August 1949 ✖Remove constraint Issue Dates: August 1949 Adjudicating Courts District of New Jersey. ✖Remove constraint Adjudicating Courts: District of New Jersey.

Refine by:

  • 2526. Adulteration and misbranding of phenobarbital sodium tablets and misbranding of atropine sulfate tablets. U. S. v. 95 Bottles, etc.1

  • Retort Pharmaceutical Co., Inc., a wholly owned subsidiary of Cole Laboratories, Inc.; Long Island City, N. Y. The phenobarbital sodium tablets1